Sup-Icu RENal (SIREN)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3350 participants.
Also called NCT02718261
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 3,350 participants
- Registry
-
NCT02718261
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT02718261. Randomized; triple masking; primary purpose other. Start 2016-02 (actual); primary completion 2018-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Sup-Icu RENal (SIREN)
- Acronym
- SIREN
- Condition
- Critical Illness
- Condition
- Acute Kidney Injury
- Condition
- End-stage Renal Disease
- Condition
- Renal Replacement Therapy
- Condition
- Proton Pump Inhibitor
- Intervention (Drug)
- Pantoprazole
- Intervention (Drug)
- Saline 0.9% (matching placebo)
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Collaborator
- Copenhagen University Hospital, Rigshospitalet
Record details
- Record id
cardio:ct-nct02718261- Content hash
2b28dd8d70bf5580bcc5f6a2ab667a423e37c90aa8e36a2e15378e2d1a26f5bb